Ionis Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
137.27 M |
Public Float |
105.61 M |
Ionis Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.48 |
Market Cap |
$9.06 B |
Shares Outstanding |
140.32 M |
Public Float |
124.9 M |
Ionis Pharmaceuticals Inc. | |
Stock Exchange | SIX Swiss Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
137.27 M |
Public Float |
105.61 M |
Address |
2855 Gazelle Court Carlsbad California 92010 United States |
Employees | - |
Website | http://www.ionispharm.com |
Updated | 07/08/2019 |
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. |